Clinical OMICs - Issue 8 - (Page 15)

Empowering Personalized Cancer Treatment CompleteSM Programs, comprehensive offerings for integrated results CompleteSM offering is a unique suite of common and proprietary tests intended to assist clinicians in determining treatment to improve patient outcomes. Each program integrates the most recent diagnostic and prognostic biomarkers across multiple methodologies. Through its multiple CompleteSM offerings, CGI is a center of excellence for personalized medicine. Learn more at www.cancergenetics.com increased regulatory activity over the direct-to-consumer genetic testing industry, the Affordable Care Act provisions for coverage without cost sharing of some genetic counseling and testing for women and testing for newborns, and the progress in implementation of genomics objectives in the Healthy People 2020 initiative. These actions signal an increasingly robust policy and evidentiary framework for the appropriate use of genomics to improve health. The CDC Office of Public Health Genomics is committed to: 1) identify which genomic applications are appropriate for use, which are not, and which need more evidence, 2) inform healthcare providers, payers, researchers, and the general public www.clinicalomics.com of this emerging body of information, and 3) integrate mature applications into existing healthcare and disease prevention programs. To facilitate integration of evidence-based genomics into healthcare and public health, CDC released an ongoing list of genomic applications based on levels of evidence and has promoted a proactive approach for the implementation of "tier 1" applications through partnerships and programs in public health departments. A clickable state map of public health activities was released in 2013, and an implementation tool kit was released in 2014 to help public health departments implement selected tier 1 genomic applications that could reduce morbidity and mortality in about two million people in the U.S. An increasingly active public health involvement in genomic implementation will help reduce health disparities, increase appropriate use of technologies, and potentially reduce healthcare costs. In summary, the successful implementation of genomics in practice requires an active collaboration among multiple sectors including research, practice, consumers, industry, and public health. Public health plays a key role in making the promise of genomics a reality to improve population health by identifying evidencebased applications, informing and engaging stakeholders, and through effective integration into disease prevention and healthcare programs. August 13, 2014 Clinical OMICs 15 http://www.cancergenetics.com http://ir.cancergenetics.com/ https://www.facebook.com/CancerGenetics https://twitter.com/Cancer_Genetics https://www.linkedin.com/company/cancer-genetics-inc. https://www.pinterest.com/cancergenetics/ http://www.cancergenetics.com http://www.cdc.gov/genomics/update/yr2013/nov27.htm#DTC http://www.cdc.gov/genomics/update/yr2013/nov27.htm#DTC https://www.healthcare.gov/what-are-my-preventive-care-benefits/ http://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/aca_implementation_faqs12.html http://www.cdc.gov/genomics/gtesting/tier.htm http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=15 http://www.cdc.gov/genomics/gtesting/tier.htm http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=15 http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=15 http://www.cdc.gov/genomics/ http://www.cdc.gov/genomics/implementation/states/index.htm http://www.cdc.gov/genomics/ http://www.cdc.gov/genomics/implementation/toolkit/index.htm http://www.clinicalomics.com

Table of Contents for the Digital Edition of Clinical OMICs - Issue 8

Contents

Clinical OMICs - Issue 8